Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  HIV Infection

  Free Subscription


09.05.2022

5 AIDS
3 Antimicrob Agents Chemother
8 Antivir Ther
3 Clin Infect Dis
1 HIV Med
9 J Acquir Immune Defic Syndr
1 J Immunol
5 J Infect Dis
1 J Med Virol
2 J Virol
1 JAMA
2 Lancet Infect Dis
1 N Engl J Med
3 Pediatrics
1 PLoS Genet
7 PLoS One
1 PLoS Pathog
2 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AIDS

  1. SHEN Y, Shiau S, Yin MT, Arpadi SM, et al
    Cytokines in HIV infection: authors' reply.
    AIDS. 2022;36:908-909.
    PubMed        

  2. MUNHOZ LGC, De Moraes-Pinto MI
    Cytokines in HIV infection: different methods of assessment require different interpretations.
    AIDS. 2022;36:907-908.
    PubMed        

  3. CICHOWITZ C, Masoza T, Peck RN
    Air pollution and preclinical atherosclerotic cardiovascular disease in adolescents living with HIV: an opportunity for prevention.
    AIDS. 2022;36:901-902.
    PubMed        

  4. ROTHERAM-BORUS MJ
    Strategies to improve HIV care outcomes for people with HIV who are out of care: the need for well designed health systems.
    AIDS. 2022;36:899-900.
    PubMed        

  5. NEL J, Gupta-Wright A
    Urine tuberculosis diagnostics in patients with advanced HIV.
    AIDS. 2022;36:897-898.
    PubMed        


    Antimicrob Agents Chemother

  6. LAI MT, Feng M, Xu M, Ngo W, et al
    Doravirine and Islatravir Have Complementary Resistance Profiles and Create a Combination with a High Barrier to Resistance.
    Antimicrob Agents Chemother. 2022 May 2:e0222321. doi: 10.1128/aac.02223.
    PubMed         Abstract available

  7. GARTLAND M, Cahn P, DeJesus E, Diaz RS, et al
    Week 96 Genotypic and Phenotypic Results of the Fostemsavir Phase 3 BRIGHTE Study in Heavily Treatment-Experienced Adults Living with Multidrug-Resistant HIV-1.
    Antimicrob Agents Chemother. 2022 May 3:e0175121. doi: 10.1128/aac.01751.
    PubMed         Abstract available

  8. VAN DER LAAN LE, Garcia-Prats AJ, Schaaf HS, Chirehwa M, et al
    Pharmacokinetics and Dose Optimization Strategies of Para-Aminosalicylic Acid in Children with Rifampicin-Resistant Tuberculosis.
    Antimicrob Agents Chemother. 2022 May 4:e0226421. doi: 10.1128/aac.02264.
    PubMed         Abstract available


    Antivir Ther

  9. UGARTE A, De la Mora L, Martinez-Rebollar M, Mallolas J, et al
    An unexpected adverse effect: Elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide-induced cholestasis.
    Antivir Ther. 2021;26.
    PubMed        

  10. LEE JE, Lee SO, Heo J, Kim DW, et al
    Comparative outcomes of lopinavir/ritonavir and hydroxychloroquine for the treatment of COVID-19 with mild-to-moderate severity: A retrospective observational study.
    Antivir Ther. 2021;26.
    PubMed         Abstract available

  11. YANG T, Oliyai R, Kent KM
    The making of the one pill-Developing single tablet regimens for HIV and for HCV.
    Antivir Ther. 2022;27:13596535211067606.
    PubMed         Abstract available

  12. SCHINAZI RF, Patel D, Ehteshami M
    The best backbone for HIV prevention, treatment, and elimination: Emtricitabine+tenofovir.
    Antivir Ther. 2022;27:13596535211067599.
    PubMed         Abstract available

  13. ALTON G, Samuel C, Reddi A
    Providing access to high-quality, low-cost medicines across low and middle-income countries (LMICs), working with governments and generic manufacturers around the globe - A business case.
    Antivir Ther. 2022;27:13596535211068617.
    PubMed         Abstract available

  14. CHOUDHARY MC, Mellors JW
    The transformation of HIV therapy: One pill once a day.
    Antivir Ther. 2022;27:13596535211062396.
    PubMed         Abstract available

  15. ABDOOL KARIM SS, Baxter C, Abdool Karim Q
    Advancing HIV prevention using tenofovir-based pre-exposure prophylaxis.
    Antivir Ther. 2022;27:13596535211067589.
    PubMed         Abstract available

  16. LEE WA, Cheng AK
    Tenofovir alafenamide fumarate.
    Antivir Ther. 2022;27:13596535211067600.
    PubMed         Abstract available


    Clin Infect Dis

  17. PRICE JC, Ma Y, Kuniholm MH, Adimora AA, et al
    HIV is associated with elevated FibroScan-AST (FAST) score.
    Clin Infect Dis. 2022 May 3. pii: 6577095. doi: 10.1093.
    PubMed         Abstract available

  18. SCHIM VAN DER LOEFF MF, Zondag H, Bruisten S, Jongen VW, et al
    Does Previous Syphilis Alter the Course of Subsequent Episodes of Syphilis?
    Clin Infect Dis. 2021 Sep 21. pii: 6373532. doi: 10.1093.
    PubMed        

  19. TULLY DC, Hahn JA, Bean DJ, Evans JL, et al
    Identification of Genetically Related HCV Infections Among Self-Described Injecting Partnerships.
    Clin Infect Dis. 2021 Aug 27. pii: 6358610. doi: 10.1093.
    PubMed         Abstract available


    HIV Med

  20. GRIMSHAW C, Trayner KMA
    Editorial on 'Epidemiology of HIV infection and associated behaviours among people who inject drugs in England, Wales, and Northern Ireland: nearly 40 years on'.
    HIV Med. 2022 May 4. doi: 10.1111/hiv.13300.
    PubMed        


    J Acquir Immune Defic Syndr

  21. WOOD BR, Bauer K, Lechtenberg R, Buskin SE, et al
    Direct and indirect effects of a Project ECHO longitudinal clinical tele-mentoring program on viral suppression for persons with HIV: a population-based analysis.
    J Acquir Immune Defic Syndr. 2022 Apr 29. pii: 00126334-990000000-00033.
    PubMed         Abstract available

  22. HAMILTON DT, Agutu C, Babigumira JB, van der Elst E, et al
    Modeling the Impact of HIV-1 Nucleic Acid Testing among Symptomatic Adult Outpatients in Kenya.
    J Acquir Immune Defic Syndr. 2022 May 4. pii: 00126334-990000000-00040.
    PubMed         Abstract available

  23. ROY CARDINAL MH, Durand M, Chartrand-Lefebvre C, Soulez G, et al
    Associative prediction of carotid artery plaques based on ultrasound strain imaging and cardiovascular risk factors in people living with HIV and age-matched control subjects of the CHACS cohort.
    J Acquir Immune Defic Syndr. 2022 May 4. pii: 00126334-990000000-00041.
    PubMed         Abstract available

  24. SEVELIUS JM, Dilworth SE, Reback CJ, Chakravarty D, et al
    Randomized Controlled Trial of Healthy Divas: A Gender-Affirming, Peer-Delivered Intervention to Improve HIV Care Engagement among Transgender Women Living with HIV.
    J Acquir Immune Defic Syndr. 2022 May 3. pii: 00126334-990000000-00039.
    PubMed         Abstract available

  25. CLOSSON K, Lee M, Gibbs A, Nicholson V, et al
    Sexual relationship power equity is associated with consistent condom use and fewer experiences of recent violence among women living with HIV in Canada.
    J Acquir Immune Defic Syndr. 2022 Apr 29. pii: 00126334-990000000-00036.
    PubMed         Abstract available

  26. MCMAHON DE, Chemtai L, Grant M, Singh R, et al
    Understanding Diagnostic Delays for Kaposi Sarcoma in Kenya: A Qualitative Study.
    J Acquir Immune Defic Syndr. 2022 May 2. pii: 00126334-990000000-00037.
    PubMed         Abstract available

  27. HECHTER RC, Bruxvoort KJ, Zhou H, Towner WJ, et al
    Sexually transmitted infections among men and transgender women using HIV pre-exposure prophylaxis in a large integrated health system- a cohort study.
    J Acquir Immune Defic Syndr. 2022 May 2. pii: 00126334-990000000-00038.
    PubMed         Abstract available

  28. NEARY J, Bulterys MA, Ogutu EA, O'Malley G, et al
    Pediatric saliva-based HIV testing: healthcare worker and caregiver acceptability.
    J Acquir Immune Defic Syndr. 2022 Apr 29. pii: 00126334-990000000-00032.
    PubMed         Abstract available

  29. RAMCHANDANI MS, Berzkalns A, Cannon CA, Dombrowski JC, et al
    A De-medicalized Model to Provide PrEP in a Sexual Health Clinic.
    J Acquir Immune Defic Syndr. 2022 Apr 29. pii: 00126334-990000000-00034.
    PubMed         Abstract available


    J Immunol

  30. TARIQ M, Gallien S, Surenaud M, Wiedemann A, et al
    Profound Defect of Amphiregulin Secretion by Regulatory T Cells in the Gut of HIV-Treated Patients.
    J Immunol. 2022 May 2. pii: jimmunol.2100725. doi: 10.4049/jimmunol.2100725.
    PubMed         Abstract available


    J Infect Dis

  31. JACOBS JL, Naqvi A, Shah FA, Boltz VF, et al
    Plasma SARS-CoV-2 RNA levels as a biomarker of lower respiratory tract SARS-CoV-2 infection in critically ill patients with COVID-19.
    J Infect Dis. 2022 May 2. pii: 6576503. doi: 10.1093.
    PubMed         Abstract available

  32. CINDI Z, Kawuma AN, Maartens G, Bradford Y, et al
    Pharmacogenetics of dolutegravir plasma exposure among Southern Africans living with HIV.
    J Infect Dis. 2022 May 4. pii: 6580078. doi: 10.1093.
    PubMed         Abstract available

  33. MOHAREB AM, Liu AF, Kim AY, Coffie PA, et al
    Clearance of hepatitis B "e" antigen in untreated chronic HBV infection: a systematic review and meta-analysis.
    J Infect Dis. 2022 May 2. pii: 6576758. doi: 10.1093.
    PubMed         Abstract available

  34. GIBBS A, Healy K, Kaldhusdal V, Sundling C, et al
    MAIT cells are preserved in the cervical mucosa of HIV-infected women and exhibit a dominant expression of the TRAV1-2-TRAJ20 TCRalpha chain.
    J Infect Dis. 2022 May 2. pii: 6576501. doi: 10.1093.
    PubMed         Abstract available

  35. WALKER NF, Karim F, Moosa M, Moodley S, et al
    Elevated Plasma Matrix Metalloproteinase-8 associates with Sputum Culture Positivity in Pulmonary Tuberculosis.
    J Infect Dis. 2022 May 1. pii: 6576469. doi: 10.1093.
    PubMed         Abstract available


    J Med Virol

  36. LALLOGO TD, Djigma FW, Sorgho PA, Martinson JJ, et al
    KIR2DL5B and HLA DRB1*12 alleles seems to be associated with protection against HIV-1 in serodiscordant couples in Burkina Faso.
    J Med Virol. 2022 May 2. doi: 10.1002/jmv.27821.
    PubMed         Abstract available


    J Virol

  37. SACKS D, Wiehe K, Morris L, Moore PL, et al
    Complementary Roles of Antibody Heavy and Light Chain Somatic Hypermutation in Conferring Breadth and Potency to the HIV-1-Specific CAP256-VRC26 bNAb Lineage.
    J Virol. 2022 May 5:e0027022. doi: 10.1128/jvi.00270.
    PubMed         Abstract available

  38. BUTTA GM, Bozzi G, Gallo G, Copaloni G, et al
    Heterogeneity of Latency Establishment in the Different Human CD4(+) T Cell Subsets Stimulated with IL-15.
    J Virol. 2022 May 2:e0037922. doi: 10.1128/jvi.00379.
    PubMed         Abstract available


    JAMA

  39. MCCLYMONT E, Albert AY, Alton GD, Boucoiran I, et al
    Association of SARS-CoV-2 Infection During Pregnancy With Maternal and Perinatal Outcomes.
    JAMA. 2022 May 2. pii: 2792031. doi: 10.1001/jama.2022.5906.
    PubMed         Abstract available


    Lancet Infect Dis

  40. NDJEKA N, Campbell JR, Meintjes G, Maartens G, et al
    Treatment outcomes 24 months after initiating short, all-oral bedaquiline-containing or injectable-containing rifampicin-resistant tuberculosis treatment regimens in South Africa: a retrospective cohort study.
    Lancet Infect Dis. 2022 May 2. pii: S1473-3099(21)00811.
    PubMed         Abstract available

  41. STEED D, Collins J, Farris AB, Guarner J, et al
    Haemophagocytic lymphohistiocytosis associated with bartonella peliosis hepatis following kidney transplantation in a patient with HIV.
    Lancet Infect Dis. 2022 Apr 29. pii: S1473-3099(22)00276.
    PubMed         Abstract available


    N Engl J Med

  42. GRAY G, Collie S, Goga A, Garrett N, et al
    Effectiveness of Ad26.COV2.S and BNT162b2 Vaccines against Omicron Variant in South Africa.
    N Engl J Med. 2022 May 4. doi: 10.1056/NEJMc2202061.
    PubMed        


    Pediatrics

  43. KHAN DSA, Naseem R, Salam RA, Lassi ZS, et al
    Interventions for High-Burden Infectious Diseases in Children and Adolescents: A Meta-analysis.
    Pediatrics. 2022;149.
    PubMed         Abstract available

  44. FANTAYE AW, Buh AW, Idriss-Wheeler D, Fournier K, et al
    Interventions Promoting Child Sexual and Reproductive Health and Rights in LMICs: A Systematic Review.
    Pediatrics. 2022;149.
    PubMed         Abstract available

  45. HOLLAND-HALL C, Bonny AE
    Testing for Sexually Transmitted Infections: Providers Cannot Opt Out of the Conversation.
    Pediatrics. 2022;149.
    PubMed        


    PLoS Genet

  46. TISTHAMMER KH, Solis C, Orcales F, Nzerem M, et al
    Assessing in vivo mutation frequencies and creating a high-resolution genome-wide map of fitness costs of Hepatitis C virus.
    PLoS Genet. 2022;18:e1010179.
    PubMed         Abstract available


    PLoS One

  47. DONG L, Bogart LM, Gandhi P, Aboagye JB, et al
    A qualitative study of COVID-19 vaccine intentions and mistrust in Black Americans: Recommendations for vaccine dissemination and uptake.
    PLoS One. 2022;17:e0268020.
    PubMed         Abstract available

  48. BENDER IGNACIO RA, Long J, Saha A, Nguyen FK, et al
    Mycobacterium tuberculosis infection, immune activation, and risk of HIV acquisition.
    PLoS One. 2022;17:e0267729.
    PubMed         Abstract available

  49. FOLAYAN MO, Aliyu S, Oginni A, Ezechi O, et al
    Effectiveness of three delivery models for promoting access to pre-exposure prophylaxis in HIV-1 serodiscordant couples in Nigeria.
    PLoS One. 2022;17:e0268011.
    PubMed         Abstract available

  50. TAYLOR MM, Wi T, Gerbase A, Thwin SS, et al
    Assessment of country implementation of the WHO global health sector strategy on sexually transmitted infections (2016-2021).
    PLoS One. 2022;17:e0263550.
    PubMed         Abstract available

  51. KHOLODNAIA A, So-Armah K, Cheng D, Gnatienko N, et al
    Impact of illicit opioid use on markers of monocyte activation and systemic inflammation in people living with HIV.
    PLoS One. 2022;17:e0265504.
    PubMed         Abstract available

  52. TSCHUMI N, Lerotholi M, Kopo M, Kao M, et al
    Assessment of a viral load result-triggered automated differentiated service delivery model for people taking ART in Lesotho (the VITAL study): Study protocol of a cluster-randomized trial.
    PLoS One. 2022;17:e0268100.
    PubMed         Abstract available

  53. VILLANUEVA M, Miceli J, Speers S, Nichols L, et al
    Advancing data to care strategies for persons with HIV using an innovative reconciliation process.
    PLoS One. 2022;17:e0267903.
    PubMed         Abstract available


    PLoS Pathog

  54. WELBOURN S, Chakraborty S, Yang JE, Gleinich AS, et al
    A neutralizing antibody target in early HIV-1 infection was recapitulated in rhesus macaques immunized with the transmitted/founder envelope sequence.
    PLoS Pathog. 2022;18:e1010488.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  55. OLABODE AS, Ng GT, Wade KE, Salnikov M, et al
    Revisiting the recombinant history of HIV-1 group M with dynamic network community detection.
    Proc Natl Acad Sci U S A. 2022;119:e2108815119.
    PubMed         Abstract available

  56. KAVAKLI KC, Rotondi V
    US foreign aid restrictions and maternal and children's health: Evidence from the "Mexico City Policy".
    Proc Natl Acad Sci U S A. 2022;119:e2123177119.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: